» Articles » PMID: 32799894

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Coronavirus Disease 19 (COVID-19) - Anatomic Pathology Perspective on Current Knowledge

Overview
Journal Diagn Pathol
Publisher Biomed Central
Specialty Pathology
Date 2020 Aug 18
PMID 32799894
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The world is currently witnessing a major devastating pandemic of Coronavirus disease-2019 (COVID-19). This disease is caused by a novel coronavirus named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). It primarily affects the respiratory tract and particularly the lungs. The virus enters the cell by attaching its spike-like surface projections to the angiotensin-converting enzyme-2 (ACE-2) expressed in various tissues. Though the majority of symptomatic patients have mild flu-like symptoms, a significant minority develop severe lung injury with acute respiratory distress syndrome (ARDS), leading to considerable morbidity and mortality. Elderly patients with previous cardiovascular comorbidities are particularly susceptible to severe clinical manifestations. BODY: Currently, our limited knowledge of the pathologic findings is based on post-mortem biopsies, a few limited autopsies, and very few complete autopsies. From these reports, we know that the virus can be found in various organs but the most striking tissue damage involves the lungs resulting almost always in diffuse alveolar damage with interstitial edema, capillary congestion, and occasional interstitial lymphocytosis, causing hypoxia, multiorgan failure, and death. A few pathology studies have also reported intravascular microthrombi and pulmonary thrombembolism. Although the clinical presentation of this disease is fairly well characterized, knowledge of the pathologic aspects remains comparatively limited.

Conclusion: In this review, we discuss clinical, pathologic, and genomic features of COVID-19, review current hypotheses regarding the pathogenesis, and briefly discuss the clinical characteristics. We also compare the salient features of COVID-19 with other coronavirus-related illnesses that have posed significant public health issues in the past, including SARS and the Middle East Respiratory Syndrome (MERS).

Citing Articles

Hospital-based cross-sectional study on the clinical characteristics of children with severe acute respiratory infections in Hungary.

Orosz N, Gomori G, Battamir U, Nagy A BMC Infect Dis. 2024; 24(1):1268.

PMID: 39521980 PMC: 11549780. DOI: 10.1186/s12879-024-10186-6.


Sero-prevalence of Toxoplasma gondii before and during the COVID-19 pandemic in Northwestern Iran.

Asfaram S, Iranpour S, Molaei S, Abdollahzadeh H, Faraji F, Aminizadeh S BMC Infect Dis. 2024; 24(1):834.

PMID: 39152395 PMC: 11328482. DOI: 10.1186/s12879-024-09724-z.


NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.

Balachandran H, Kroll K, Terry K, Manickam C, Jones R, Woolley G PLoS Pathog. 2024; 20(8):e1012439.

PMID: 39133756 PMC: 11341101. DOI: 10.1371/journal.ppat.1012439.


Inhibition of SARS-CoV-2-Induced NLRP3 Inflammasome-Mediated Lung Cell Inflammation by Triphala-Loaded Nanoparticle Targeting Spike Glycoprotein S1.

Chittasupho C, Umsumarng S, Srisawad K, Arjsri P, Phongpradist R, Samee W Pharmaceutics. 2024; 16(6).

PMID: 38931873 PMC: 11206841. DOI: 10.3390/pharmaceutics16060751.


Prognostic Factors for Mortality in Adults Hospitalized With COVID-19 Infection in the Americas.

Tawde P, Igburuke L, Olanipekun D, Marwaha V, Lambo J Cureus. 2024; 16(2):e55044.

PMID: 38550464 PMC: 10977156. DOI: 10.7759/cureus.55044.


References
1.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

2.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

3.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

4.
Kanne J . Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist. Radiology. 2020; 295(1):16-17. PMC: 7233362. DOI: 10.1148/radiol.2020200241. View

5.
Escher F, Pietsch H, Aleshcheva G, Bock T, Baumeier C, Elsaesser A . Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail. 2020; 7(5):2440-2447. PMC: 7307078. DOI: 10.1002/ehf2.12805. View